最新资讯
-
BusinessExpansion of γ-Butyrolactone (GBL) Production Capacity
-
Financial ResultsConsolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024 (Under IFRS)
-
BusinessGlobal, Phase 3b study of Oral Edaravone in ALS
-
BusinessLaunch of REMLEAS® capsules 40mg for Treatment of Tardive Dyskinesia in three ASEAN countries
-
BusinessTransfer of Qualicaps Co., Ltd.
-
BusinessMasdar, Mitsubishi Chemical Group and INPEX Agree on Joint Feasibility Study for Carbon Recycle Chemicals Project in Abu Dhabi, UAE
- Targeting World’s First Polypropylene Produced from CO2 and Green Hydrogen -
通知
-
Conference video of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024
-
Announcement of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024
-
The 18th Ordinary General Meeting of Shareholders (Archived Conference / Summary of Questions and Answers on the Day and Answers to Pre-submitted Questions)
-
Voting Results of the 18th Ordinary General Meeting of Shareholders
-
Notice of the Resolutions Adopted at the 18th Ordinary General Meeting of Shareholders
三菱化学集团的业务
在 "One Company, One Team"的新政策下,我们的目标是为所有利益相关者实现价值最大化。

支持三菱化学集团价值创造的三个领域
三菱化学集团在功能商品、材料和健康保健三个领域开展业务。
面向股东・投资者信息
介绍三菱化学集团株式会社为谋求资产效率提升和财务基础再强化,
致力于提升企业价值的IR信息相关情况。